News from SGC

SGC Symposium June 4-5, 2014: Epigenetic Mechanisms in Cancer 2014; Registration now open

Posted on Wednesday 26th of March 2014

SGC and DiscoveRx® Corporation Publish Study Identifying Clinical Kinase Inhibitors that Potently Cross-React with Bromodomain Epigenetic Reader Proteins

Posted on Tuesday 25th of February 2014

The Structural Genomics Consortium (SGC) and DiscoveRx Corporation announced the publication of findings demonstrating that several clinical kinase inhibitors also potently inhibit diverse bromodomain epigenetic reader proteins. This study titled “Dual kinase-bromodomain inhibitors for rationally designed polypharmacology”, which appears on-line today in Nature Chemical Biology , suggests compelling new multi-targeting approaches for cancer therapy.

Bayer HealthCare to Join Not-For-Profit SGC to Accelerate Research in Epigenetics

Posted on Thursday 19th of December 2013

Bayer Inc. is pleased to announce that Bayer HealthCare has joined the SGC, a not-for-profit, public-private partnership with active research facilities at the Universities of Toronto and Oxford, UK.

Colon Cancer Researchers Target Stem Cells, Discover Viable New Therapeutic Path

Posted on Friday 13th of December 2013

An SGC collaborative study: http://www.sciencenewsline.com/articles/2013120123560003.html

Identifying drug targets one protein at a time

Posted on Tuesday 26th of November 2013

The Open Access nature of SGC work is discussed in this article on CreativeCommons.org

SGC Announces Janssen has joined Public-Private Drug Discovery Partnership

Posted on Sunday 27th of October 2013

The Structural Genomics Consortium (SGC) announced today that Janssen Pharmaceuticals NV has joined its group to partner in the investigation of epigenetics-based drug research, a new and burgeoning field in the development of future medicines.

Putting drug discovery back on target

Posted on Sunday 27th of October 2013

The SGC's Prof. Chas Bountra interviewed for the University of Oxford website. [article].

Long-time SGC friend and collaborator Prof. Tony Pawson passes away

Posted on Friday 9th of August 2013

Today we learned the sad news that Tony Pawson, a former member of the SGC Scientific Committee, and a friend and colleague of many SGC scientists, died this week. He was a fantastic person, scientist and collaborator.

SGC launches the Structure-guided Drug Discovery Coalition (SDDC) for tuberculosis and malaria

Posted on Tuesday 16th of July 2013

The Structural Genomics Consortium (SGC) recently launched a new scientific public-private partnership in tuberculosis and malaria drug discovery: the Structure-guided Drug Discovery Coalition, SDDC.

Boehringer-Ingelheim joins SGC

Posted on Tuesday 7th of May 2013

Boehringer Ingelheim announced that it has joined the Structural Genomics Consortium (SGC) for further research into incurable diseases.